Cullinan Therapeutics (CGEM) Q3 2023 Earnings

8NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-1.42
-1.14
-0.87
-0.59

Details

Expected EPS
-0.92
Actual EPS
-0.91
Surprise EPS
0.01
Surprise Percent
+1.09%

Description

Cullinan Therapeutics (CGEM) has reported earnings of -0.91 per share for Q3 2023.

0 Comments

Share your thoughts